SI-BONE, INC. Stock-Based Compensation
SI-BONE, INC. (SIBN) reported Stock-Based Compensation of $12.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-04
- SI-BONE, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $5.98M, a 10.20% decline year-over-year.
- SI-BONE, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $6.03M, a 9.58% decline year-over-year.
- SI-BONE, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $5.98M, a 2.58% decline year-over-year.
- SI-BONE, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $6.23M, a 1.27% decline year-over-year.
- SI-BONE, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $25.52M, a 1.33% decline from fiscal 2024.
- SI-BONE, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $25.87M, a 7.53% increase from fiscal 2023.
- SI-BONE, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $24.06M, a 4.32% increase from fiscal 2022.
- SI-BONE, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $23.06M, a 36.73% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $12.00M 10-Q · filed 2026-08-04 | $17.98M derived: sum of 3 quarters · filed 2026-08-04 | $24.21M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $6.03M 10-Q · filed 2026-05-11 | $12.00M derived: sum of 2 quarters · filed 2026-05-11 | $18.23M derived: sum of 3 quarters · filed 2026-05-11 | $24.89M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $5.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $12.20M derived: sum of 2 quarters · filed 2026-02-24 | $18.86M derived: sum of 3 quarters · filed 2026-08-04 | $25.52M 10-K · filed 2026-02-24 |
| 2025-09-30 | $6.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $12.88M derived: sum of 2 quarters · filed 2026-08-04 | $19.55M 10-Q · filed 2025-11-10 | $25.68M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $6.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $13.32M 10-Q · filed 2026-08-04 | $19.46M derived: sum of 3 quarters · filed 2026-08-04 | $25.76M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $6.66M 10-Q · filed 2026-05-11 | $12.80M derived: sum of 2 quarters · filed 2026-05-11 | $19.10M derived: sum of 3 quarters · filed 2026-05-11 | $25.50M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $6.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $12.44M derived: sum of 2 quarters · filed 2026-02-24 | $18.84M derived: sum of 3 quarters · filed 2026-02-24 | $25.87M 10-K · filed 2026-02-24 |
| 2024-09-30 | $6.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $12.70M derived: sum of 2 quarters · filed 2025-11-10 | $19.73M 10-Q · filed 2025-11-10 | $25.67M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $6.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $13.43M 10-Q · filed 2025-08-05 | $19.36M derived: sum of 3 quarters · filed 2026-02-24 | $25.29M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $7.03M 10-Q · filed 2025-05-06 | $12.97M derived: sum of 2 quarters · filed 2026-02-24 | $18.89M derived: sum of 3 quarters · filed 2026-02-24 | $24.89M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $5.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $11.87M derived: sum of 2 quarters · filed 2026-02-24 | $17.86M derived: sum of 3 quarters · filed 2026-02-24 | $24.06M 10-K · filed 2026-02-24 |
| 2023-09-30 | $5.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $11.93M derived: sum of 2 quarters · filed 2024-11-12 | $18.12M 10-Q · filed 2024-11-12 | $24.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $12.19M 10-Q · filed 2024-08-06 | $18.07M derived: sum of 3 quarters · filed 2025-02-25 | $24.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $6.19M 10-Q · filed 2024-05-07 | $12.07M derived: sum of 2 quarters · filed 2025-02-25 | $18.00M derived: sum of 3 quarters · filed 2025-02-25 | $23.75M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $11.80M derived: sum of 2 quarters · filed 2025-02-25 | $17.55M derived: sum of 3 quarters · filed 2025-02-25 | $23.06M 10-K · filed 2025-02-25 |
| 2022-09-30 | $5.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $11.67M derived: sum of 2 quarters · filed 2023-11-07 | $17.18M 10-Q · filed 2023-11-07 | $21.52M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $5.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $11.26M 10-Q · filed 2023-08-08 | $15.60M derived: sum of 3 quarters · filed 2023-08-08 | $19.84M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $5.51M 10-Q · filed 2023-05-02 | $9.85M derived: sum of 2 quarters · filed 2023-05-02 | $14.09M derived: sum of 3 quarters · filed 2023-05-02 | $18.34M derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | $4.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $8.58M derived: sum of 2 quarters · filed 2023-03-02 | $12.84M derived: sum of 3 quarters · filed 2023-03-02 | $16.87M 10-K · filed 2023-03-02 |
| 2021-09-30 | $4.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $8.50M derived: sum of 2 quarters · filed 2022-11-08 | $12.53M 10-Q · filed 2022-11-08 | $15.70M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $4.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $8.29M 10-Q · filed 2022-08-09 | $11.46M derived: sum of 3 quarters · filed 2022-08-09 | $14.64M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $4.03M 10-Q · filed 2022-05-10 | $7.20M derived: sum of 2 quarters · filed 2022-05-10 | $10.38M derived: sum of 3 quarters · filed 2022-05-10 | $13.34M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.35M derived: sum of 2 quarters · filed 2022-03-01 | $9.30M derived: sum of 3 quarters · filed 2022-03-01 | $11.93M 10-K · filed 2022-03-01 |
| 2020-09-30 | $3.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $6.13M derived: sum of 2 quarters · filed 2021-11-09 | $8.76M 10-Q · filed 2021-11-09 | $10.63M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $5.58M 10-Q · filed 2021-08-04 | $7.45M derived: sum of 3 quarters · filed 2021-08-04 | $9.36M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $2.62M 10-Q · filed 2021-05-04 | $4.49M derived: sum of 2 quarters · filed 2021-05-04 | $6.40M derived: sum of 3 quarters · filed 2021-05-04 | $8.21M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $3.78M derived: sum of 2 quarters · filed 2021-03-10 | $5.59M derived: sum of 3 quarters · filed 2021-03-10 | $7.46M 10-K · filed 2021-03-10 |
| 2019-09-30 | $1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $3.73M derived: sum of 2 quarters · filed 2020-11-03 | $5.60M 10-Q · filed 2020-11-03 | $6.83M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $3.69M 10-Q · filed 2020-08-04 | $4.92M derived: sum of 3 quarters · filed 2020-08-04 | $5.24M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $1.87M 10-Q · filed 2020-05-05 | $3.10M derived: sum of 2 quarters · filed 2020-05-05 | $3.43M derived: sum of 3 quarters · filed 2020-05-05 | $3.79M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $1.56M derived: sum of 2 quarters · filed 2020-03-11 | $1.92M derived: sum of 3 quarters · filed 2020-03-11 | $2.31M 10-K · filed 2020-03-11 |
| 2018-09-30 | $327.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $689.00K derived: sum of 2 quarters · filed 2019-11-12 | $1.08M 10-Q · filed 2019-11-12 | $1.48M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $362.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $754.00K 10-Q · filed 2019-08-07 | $1.15M derived: sum of 3 quarters · filed 2019-08-07 | |
| 2018-03-31 | $392.00K 10-Q · filed 2019-05-09 | $792.00K derived: sum of 2 quarters · filed 2019-05-09 | ||
| 2017-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $1.44M 10-K · filed 2019-03-14 | ||
| 2017-09-30 | $1.04M 10-Q · filed 2018-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |